SCCM
Log In
Forgot username or password?
New User? Sign Up Free.

Tag: Anticoagulation

Anticoagulation Issues
This presentation covers treating anticoagulation issues seen in COVID-19 patients. This is SCCM curated COVID-19 microlearning content.

Anticoagulation, Coronavirus, COVID-19


SCCM Pod-VCCR2 New Onset Atrial Fibrillation in Septic Shock
Sean P. Kane, PharmD, BCPS, speaks with Ishaq Lat, PharmD, about new onset atrial fibrillation in septic shock. In the epsiode, the issue of rate versus rhythm control is discussed as well as the need for anticoagulation among this patient population.

Anticoagulation, Sepsis, Septic Shock


Anticoagulation Issues in COVID-19
This presentation covers anticoagluation issues seen with COVID-19 patients. This is SCCM curated COVID-19 microlearning content.

Anticoagulation, Coronavirus, COVID-19


Are you using typical DVT prophylaxis or something more, such as therapeutic anticoagulation?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on October 14, 2020.

Anticoagulation, Coronavirus, COVID-19, DVT


Are you using typical DVT prophylaxis or something more, such as therapeutic anticoagulation?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on October 14, 2020.

Anticoagulation, Coronavirus, COVID-19


Can you discuss coagulability issues?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on May 13th, 2020.

Anticoagulation, Coronavirus, COVID-19


Clinical Outcomes With the Use of Prophylactic Versus Therapeutic Anticoagulation in Coronavirus Disease 2019
From Critical Care Explorations

In this study, the authors found an increase in inhospital mortality was observed among patients on preemptive therapeutic anticoagulation.

Anticoagulation, Coronavirus, COVID-19


Coagulopathy of Coronavirus Disease 2019
From Critical Care Medicine. Recent studies have reported a high incidence of thrombotic events in COVID-19. However, the significance of thromboembolic complications has not been widely appreciated. The purpose of this review is to provide current knowledge of this serious problem.

Anticoagulation, Coronavirus, COVID-19, Therapies


Higher Intensity Thromboprophylaxis Regimens and Pulmonary Embolism in Critically Ill Coronavirus Disease 2019 Patients
From Critical Care Medicine. In this study from Belgium, the authors assessed the role of thromboprophylaxis regimens on the occurrence of pulmonary embolism in coronavirus disease 2019 patients.

Anticoagulation, Coronavirus, COVID-19


How do we prevent VTEs and how do we survey for them? Should patients receive standard prophylaxis? Should all ventilated patients receive full-dose anticoagulation? What are your practices and how have you approached this at your center?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on December 9, 2020.

Anticoagulation, Coronavirus, COVID-19


How should anticoagulation be approached in the critically ill patient with COVID-19?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on September 9, 2020.

Anticoagulation, Coronavirus, COVID-19, Therapies


Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients Receiving Prophylactic Anticoagulation
From Critical Care Medicine. Deep venous thrombosis is very common in critically ill patients with coronavirus disease 2019, so the authors describe the prevalence of venous thromboembolism in critically ill patients receiving different regimens of prophylactic anticoagulation.

Anticoagulation, Coronavirus, COVID-19


Integral Use of Thromboelastography With Platelet Mapping to Guide Appropriate Treatment, Avoid Complications, and Improve Survival of Patients With Coronavirus Disease 2019–Related Coagulopathy
From Critical Care Explorations

In this study, the authors round that thromboelastography with platelet mapping better characterizes the spectrum of coronavirus disease 2019 coagulation-related abnormalities and may guide more tailored, patient-specific therapies in thostudyse infected with coronavirus disease 2019.

Anticoagulation, Coronavirus, COVID-19, Diagnosis and Testing


Letter to Editor: In Response to "Coagulopathy of Coronavirus Disease 2019"
From Critical Care Medicine. This Letter to the Editor is in response to the article "Coagulopathy of Coronavirus 2019" by Iba et a.

Anticoagulation, Coronavirus, COVID-19


Subcutaneous Enoxaparin Safely Facilitates Bedside Sustained Low-Efficiency Hemodialysis in Hypercoagulopathic Coronavirus Disease 2019 Patients - A Proof-of-Principle Trial
This study describes a simple and safe protocol of anticoagulation with low molecular weight heparin (LMWH) in combination with bedside sustained low efficiency hemodialysis (SLED) in COVID-19 patients.

Anticoagulation, Coronavirus, COVID-19


Thromboembolism, Hypercoagulopathy, and Antiphospholipid Antibodies in Critically Ill Coronavirus Disease 2019 Patients: A Before and After Study of Enhanced Anticoagulation
From Critical Care Explorations

In this study, the authors sought to determine the prevalence of thrombotic events, functional coagulation tests, inflammatory biomarkers, and antiphospholipid antibodies before and after enhanced anticoagulation in critically ill coronavirus disease 2019 patients.

Anticoagulation, Coronavirus, COVID-19


What are the indications for post-discharge thromboprophylaxis?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on November 4, 2020.

Anticoagulation, Coronavirus, COVID-19


What are the options for diagnosis, workup, and treatment for a hypercoagulable state?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on July 8th, 2020.

Anticoagulation, Coronavirus, COVID-19


What are your thoughts on anticoagulation treatment?
In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues.

Anticoagulation, Coronavirus, COVID-19, Therapies


What is double anticoagulation prophylaxis?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on October 14, 2020.

Anticoagulation, Coronavirus, COVID-19


What is double anticoagulation prophylaxis?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on October 14, 2020.

Anticoagulation, Coronavirus, COVID-19, Therapies


What is the recommended role of serial laboratory studies, including troponin, creatin kinase and D-dimer in the management of a hypercoagulable state?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered.

Anticoagulation, Clinical Trials, Coronavirus, COVID-19, Therapies


What is your anticoagulation protocol in COVID-19 patients?
In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues. Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were also answered. Recorded on: Friday, May 22, 2020

Anticoagulation, Coronavirus, COVID-19


What is your experience with COVID-19 patients and ECMO?
Despite remdesivir, dexamethasone, and twice-daily anticoagulation, a patient’s condition continues to deteriorate. The patient is intubated, and every possible ventilation mode has been tried. The P/F ratio is decreasing, and pressure ventilation is not working. What is your experience with COVID-19 patients and ECMO? This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on November 4, 2020.

Anticoagulation, Antivirals, Coronavirus, Corticosteriods, COVID-19, Intubation


Which medications are used for a hemodynamically unstable intubated patient who is progressing toward or has developed acute respiratory distress syndrome? Are remdesivir or steroids used? What about anticoagulation, given the high risk of thrombosis?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on November 4, 2020.

Anticoagulation, Antivirals, Coronavirus, Corticosteriods, COVID-19, Hemodynamic Support